Facebook Instagram Pinterest Reddit Tumblr Twitter Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 141

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

January 2026 Psychedelic Bill Round-up

The Psychedelic News Feed: January 19 – 25, 2025

“Changes Are Never Linear”: Joost Breeksema on the Human Side of Psychedelic Therapy

Op-Ed: From Psychedelic Prohibition to Psychedelic Public Health

Pα+ Psychedelic Bulletin #218: FDA’s Farchione Says Psychedelic INDs Are “a Third” of Her Workload; Ipsos/Psychedelic Alpha Poll; Reunion Eyes Single Phase 3 in...

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial...

Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety...

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform...

PT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration,...

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit...

Acid for Anxiety: Fast and Lasting Anxiolytic Effects of LSD

PT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical...

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...

1...140141142...307Page 141 of 307

EDITOR PICKS

January 2026 Psychedelic Bill Round-up

The Psychedelic News Feed: January 19 – 25, 2025

“Changes Are Never Linear”: Joost Breeksema on the Human Side of...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr Twitter Youtube
    ©